Managing heart failure in a specialist clinic

Journal of the Royal College of Physicians of London

Volumn 31, Issue 3, 1997, Pages 276-279

  Houghton, Andrew R ^a   Cowley, A J ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; COST EFFECTIVENESS ANALYSIS; ECHOCARDIOGRAPHY; GENERAL PRACTICE; HEALTH CARE UTILIZATION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; PATIENT REFERRAL;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE FACILITIES; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ENGLAND; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; REFERRAL AND CONSULTATION; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0031007870     PISSN: 00358819     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285:1441-6.
2. Wheeldon NM, MacDonald TM, Flucker CJ, McKendrick AD, et al. Echocardiography in chronic heart failure in the community. Q J Med 1993;86:17-23.
3. Clarke KW, Gray D, Hampton JR. The prevalence of heart failure estimated from prescription data. [abstract] Br Heart J 1994;71(Suppl):P33.
4. McMurray J, McDonagh T, Morrison CE, Dargie HJ. Trends in hospitalization for heart failure in Scotland 1980-1990. Eur Heart J 1993;14:1158-62.
5. Remes J, Miettinen H, Reunanen A, Pyorala K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991;12:315-21.
6. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-35.
7. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive failure. N Engl J Med 1991;325:293-302.
8. Cohn JN, Johnson G, Ziesche S, Cobb F, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303-10.
9. Clarke KW, Gray D, Hampton JR. Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J 1994;71:584-7.
10. Francis CM, Caruana L, Kearney P, Love M, et al. Open access echocardiography in the management of heart failure in the community. Br Med J 1995;310:634-6.
11. Murphy JJ, Frain JPJ, Bossingham CM. 'Open access' to echocardiography for suspected heart failure: does it work? [abstract] Br Heart J 1995;73(Suppl):P39.
12. British National Formulary. London: BMA and Royal Pharmaceutical Society of Great Britain, 1995;29:82.
13. McMurray J, Hart W, Rhodes G. An evaluation of the cost of heart failure to the National Health Service in the UK. Br J Med Economics 1993;6:99-110.
14. The Task Force on Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis of heart failure. Eur Heart J 1995;16:741-51.
15. Hart W, Rhodes G, McMurray J. The cost effectiveness of enalapril in the treatment of chronic heart failure. Br J Med Economics 1993;6:91-8.
16. Houghton AR, Cowley AJ. The use of angiotensin-converting enzyme inhibitors in heart failure by general practitioners: results of a postal survey, [abstract] Eur Heart J 1996;17 (Suppl):61.